Market Manipulation
Lunai Bioworks Sues Alleged Naked Short Sellers for Securities Fraud
Lunai Bioworks filed a federal lawsuit accusing unidentified traders of naked short selling, with failure-to-deliver rates reaching 234.6 times the baseline and trading volumes exceeding outstanding shares by 15-fold, highlighting ongoing concerns about market manipulation in small-cap stocks.
Datavault AI Files Federal Lawsuit Alleging Market Manipulation and Defamation
Datavault AI has filed a federal lawsuit alleging securities fraud, defamation, and market manipulation through naked short selling and online misinformation campaigns targeting the company's stock.
Quantum BioPharma Ltd. Challenges Motion to Dismiss in $700 Million Market Manipulation Case
Quantum BioPharma Ltd. opposes a motion to dismiss in a significant lawsuit alleging market manipulation by major financial institutions, highlighting the potential implications for securities law enforcement and investor protection.
Quantum BioPharma Ltd. Acquires GameStop Shares in Strategic Move Against Market Manipulation
Quantum BioPharma Ltd. has purchased GameStop shares as part of its campaign against market corruption, highlighting its commitment to combating manipulative trading practices while advancing its biopharmaceutical research.
Quantum BioPharma Files $700M Market Manipulation Lawsuit Against Financial Institutions
Quantum BioPharma has initiated a significant legal action against multiple financial institutions, alleging securities law violations through market manipulation tactics between 2020 and 2024, seeking substantial damages.